SE383150B - Forfarande for framstellning av nitrerade derivat av glukagon - Google Patents
Forfarande for framstellning av nitrerade derivat av glukagonInfo
- Publication number
- SE383150B SE383150B SE7204289A SE428972A SE383150B SE 383150 B SE383150 B SE 383150B SE 7204289 A SE7204289 A SE 7204289A SE 428972 A SE428972 A SE 428972A SE 383150 B SE383150 B SE 383150B
- Authority
- SE
- Sweden
- Prior art keywords
- nitrated
- procedure
- preparation
- glucagon derivatives
- glucagon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13143771A | 1971-04-05 | 1971-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE383150B true SE383150B (sv) | 1976-03-01 |
Family
ID=22449460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7204289A SE383150B (sv) | 1971-04-05 | 1972-04-04 | Forfarande for framstellning av nitrerade derivat av glukagon |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3773744A (sv) |
| JP (1) | JPS5224023B1 (sv) |
| AU (1) | AU460061B2 (sv) |
| CA (1) | CA973171A (sv) |
| DE (1) | DE2216451A1 (sv) |
| FR (1) | FR2132452B1 (sv) |
| GB (1) | GB1357683A (sv) |
| IL (1) | IL39020A (sv) |
| NL (1) | NL7204563A (sv) |
| SE (1) | SE383150B (sv) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3897551A (en) * | 1971-04-05 | 1975-07-29 | Lilly Co Eli | Iodoglucagons and process for prolonging the biological activity of glucagon |
| US3862301A (en) * | 1973-06-18 | 1975-01-21 | Stanley M Chernish | Glucagon as a diagnostic aid in gastrointestinal radiology |
-
1971
- 1971-04-05 US US00131437A patent/US3773744A/en not_active Expired - Lifetime
-
1972
- 1972-03-15 CA CA137,141A patent/CA973171A/en not_active Expired
- 1972-03-19 IL IL39020A patent/IL39020A/xx unknown
- 1972-03-24 AU AU40384/72A patent/AU460061B2/en not_active Expired
- 1972-04-04 GB GB1548072A patent/GB1357683A/en not_active Expired
- 1972-04-04 SE SE7204289A patent/SE383150B/sv unknown
- 1972-04-05 JP JP47034305A patent/JPS5224023B1/ja active Pending
- 1972-04-05 NL NL7204563A patent/NL7204563A/xx unknown
- 1972-04-05 FR FR7211930A patent/FR2132452B1/fr not_active Expired
- 1972-04-05 DE DE19722216451 patent/DE2216451A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2216451A1 (de) | 1972-10-12 |
| JPS5224023B1 (sv) | 1977-06-28 |
| AU4038472A (en) | 1973-09-27 |
| CA973171A (en) | 1975-08-19 |
| GB1357683A (en) | 1974-06-26 |
| IL39020A0 (en) | 1972-05-30 |
| IL39020A (en) | 1975-05-22 |
| NL7204563A (sv) | 1972-10-09 |
| FR2132452A1 (sv) | 1972-11-17 |
| US3773744A (en) | 1973-11-20 |
| AU460061B2 (en) | 1975-03-25 |
| FR2132452B1 (sv) | 1975-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE392269B (sv) | Forfarande for framstellning av vissa indanyloxitetrazoler | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
| SE7511680L (sv) | Forfarande for framstellning av furanderivat | |
| SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE417318B (sv) | Forfarande for framstellning av oxofurylesterderivat av penicillin | |
| SE382980B (sv) | Forfarande for framstellning av nya derivat av hexahydrofenantridin | |
| SE393376B (sv) | Forfarande for framstellning av pyrimidinonderivat | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE409858B (sv) | Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat | |
| SE387936B (sv) | Forfarande for framstellning av substituerade metoxiaminer | |
| SE401832B (sv) | Forfarande for framstellning av derivat av 2-formyl-3-karbonamido-kinoxalin-di-n-oxider | |
| SE409866B (sv) | Forfarande for framstellning av adenosinderivat | |
| SE380520B (sv) | Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin | |
| SE383150B (sv) | Forfarande for framstellning av nitrerade derivat av glukagon | |
| SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat | |
| SE405730B (sv) | Forfarande for framstellning av kinazolinderivat | |
| NO136409C (no) | Fremgangsm}te for fremstilling av aryloksyalkyl-morfolinderivater | |
| NO137050C (no) | Fremgangsm}te til fremstilling av butyrofenonderivater | |
| SE7605364L (sv) | Forfarande for framstellning av antracenderivat | |
| SE7510790L (sv) | Forfarande for framstellning av 2- eller 3-cefemderivat | |
| SE386897B (sv) | Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler | |
| SE392902B (sv) | Forfarande for framstellning av fenylimidazolidinoner |